Assessment of public hospital drug supply financing through the public-private partnership: pharmacists' perspectives

In Nigeria, drug financing by the public has been challenged by financial constraints through public fund due to a limited fund available to the government to meet all its demands. The objectives of this study were to determine the variability of the hospital patient prices of same drugs under the P...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roland Nnaemeka Okoro (Autor), Hadiza Muhammad Muhammad (Autor), Muslim Olakunle Jamiu (Autor)
Formato: Libro
Publicado: Universidade de São Paulo, 2021-11-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cc13a61febac48cf9c45fbf9a3cac7e9
042 |a dc 
100 1 0 |a Roland Nnaemeka Okoro  |e author 
700 1 0 |a Hadiza Muhammad Muhammad  |e author 
700 1 0 |a Muslim Olakunle Jamiu  |e author 
245 0 0 |a Assessment of public hospital drug supply financing through the public-private partnership: pharmacists' perspectives 
260 |b Universidade de São Paulo,   |c 2021-11-01T00:00:00Z. 
500 |a 2175-9790 
500 |a 10.1590/s2175-97902020000419164 
520 |a In Nigeria, drug financing by the public has been challenged by financial constraints through public fund due to a limited fund available to the government to meet all its demands. The objectives of this study were to determine the variability of the hospital patient prices of same drugs under the PublicPrivate Partnership (PPP) and in Private Retail Community Pharmacy (PRCP), and to investigate the perceived efficiency and effectiveness of the PPP by comparing it with the Drug Revolving Fund (DRF) model in drug supply financing. This study was conducted in Nigeria utilizing a mixed method. Mann-Whitney U test analysis was used to compare the median drug price of the two facilities. The majority (76.19%) of the drugs were sold at a cheaper rate in the hospital than what was obtained in the PRCP with no significance difference (p > 0.05). Dominant responses from the focused group discussions supported the PPP model. This study shows that the median patient price of the basket of matched pairs of same drugs in the hospital under the PPP and in the PRCP was identical. Overall, the participants were of the opinion that the PPP model was more efficient and effective than DRFin the financing drug supply. 
546 |a EN 
690 |a Drug Revolving Fund (DRF) 
690 |a Maiduguri 
690 |a Nigeria 
690 |a Public Private Partnership (PPP) 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Brazilian Journal of Pharmaceutical Sciences, Vol 57 (2021) 
787 0 |n http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502021000100549&tlng=en 
787 0 |n https://doaj.org/toc/2175-9790 
856 4 1 |u https://doaj.org/article/cc13a61febac48cf9c45fbf9a3cac7e9  |z Connect to this object online.